基于网络的方法用于早期发病帕金森病的药物标识
Ashmita Dey1, Mrittika Chakraborty1,2, Ujjwal Maulik3
1Machine Intelligence Unit, Indian Statistical Institute, Kolkata, India.
Scientific reports
|March 28, 2025
概括
这项研究介绍了DTI-Prox,这是一种用于发现早期发病的帕金森病 (EOPD) 标志物和药物标的新方法. 它通过分析生物网络中的药物基因连接来确定潜在的新疗法.
科学领域:
- 计算生物学 计算生物学
- 基因组学就是基因组学.
- 神经科学是一个神经科学.
背景情况:
- 目前早期发病的帕金森病 (EOPD) 研究缺乏对药物-基因关系的机制性理解.
- 现有的EOPD标记不能完全解释向药物如何达到治疗效果.
研究的目的:
- 开发一个新的工作流程,DTI-Prox,用于识别被忽视的EOPD标记物和潜在的药物点.
- 阐明药物基因关系及其在EOPD中的机制基础.
主要方法:
- 利用网络近距离来量化生物网络中的药物基因连接性.
- 使用节点相似性来评估网络节点之间的功能相似性,揭示了重要的药物基因关联.
- 构建了一个功能性网络来验证已识别的药物标对.
主要成果:
- 确定了417种新的药物标对和四种新的EOPD标记:PTK2B,APOA1,A2M和BDNF.
- 在已识别的标志物中检测到神经退行过程中显著的途径丰富.
- 像阿曼塔丁 (Amantadine) 和西塔洛普拉姆 (Citalopram) 这样的优先级药物显示出由于与EOPD标记物的相互作用而具有重定向的潜力.
结论:
- DTI-Prox提供了一种强大的方法来发现EOPD生物标志物和治疗点.
- 这些发现为EOPD药物机制提供了新的见解,并为个性化医学提供了有希望的候选人.
- 这项研究强调了药物重用治疗EOPD的潜力.
相关概念视频
01:26Drug Discovery: Overview
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...